Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03624907 · ClinicalTrials.gov registry record · NA
Daily vs. Non-Daily SBRT for NSCLC
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03624907: Clinical Trial NA study, sponsored by University of Florida.
NCT03624907 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03624907, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if stereotactic body radiotherapy (SBRT) on non-consecutive days will increase the chances of curing non-small cell lung cancer when compared to daily treatment.
Primary Outcome
Control defined as Less than 20% increase in the largest dimension of treated tumor measurable by CT
Interventions
- RADIATION Daily Stereotactic Body Radiotherapy
- RADIATION Non-Daily Stereotactic Body Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-10-19 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
Why NCT03624907 stopped before completion
NCT03624907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Daily Stereotactic Body Radiotherapy is the first listed.
NCT03624907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03624907 about?
NCT03624907 is a clinical study titled "Daily vs. Non-Daily SBRT for NSCLC". The purpose of this study is to determine if stereotactic body radiotherapy (SBRT) on non-consecutive days will increase the chances of curing non-small cell lung cancer when compared to daily treatment.
What is the current status of trial NCT03624907?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2018-10-19. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT03624907?
The interventions under investigation include: Daily Stereotactic Body Radiotherapy (RADIATION), Non-Daily Stereotactic Body Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT03624907?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03624907's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI